Abstract
Helicobacter pylori infects approximately half the human population and has an unusual infective niche of the human stomach. Helicobacter pylori is a major cause of gastritis and has been classified as a group 1 carcinogen by the WHO. Treatment involves triple or quadruple antibiotic therapy, but antibiotic resistance is becoming increasingly prevalent. Helicobacter pylori expresses certain blood group related antigens (Lewis system) as a part of its lipopolysaccharide (LPS), which is thought to assist in immune evasion. Additionally, H. pylori LPS participates in adhesion to host cells alongside several adhesion proteins. This study profiled the carbohydrates of H. pylori reference strains (SS1 and 26695) using monoclonal antibodies (mAbs) and lectins, identifying interactions between two carbohydrate-targeting mAbs and multiple lectins. Atomic force microscopy (AFM) scans were used to probe lectin and antibody interactions with the bacterial surfaces. The selected mAb and lectins displayed an increased adhesive force over the surface of the curved H. pylori rods. Furthermore, this study demonstrates the ability of anti-carbohydrate antibodies to reduce the adhesion of H. pylori 26695 to human gastric adenocarcinoma cells via AFM. Targeting bacterial carbohydrates to disrupt crucial adhesion and immune evasion mechanisms represents a promising strategy for combating H. pylori infection.
Similar content being viewed by others
Introduction
Helicobacter pylori (H. pylori) is a gram-negative microorganism that infects approximately 50% of the human population and can cause a variety of pathologies including chronic gastritis and gastric polyps in up to 15% of cases, and gastric malignancies, such as gastric adenocarcinoma, in 1–2% of cases1,2,3,4. An important step in H. pylori infection involves adhesion of the microorganism to the gastric epithelium and the gastric mucosa. Boren et al. first reported that this process was associated with the histo-blood group antigen Lewis B (Leb) as well as sialyl-Lewis X (SLex)5,6,7. Adhesion is mediated by outer membrane proteins (OMPs) such as the blood group binding adhesin (BabA) and sialic acid binding adhesin (SabA) which bind to Leb and SLex respectively6,7,8,9,10,11. In addition, H. pylori has also been found to express Lewis antigens as a part of its lipopolysaccharide (LPS), thought to be a form of molecular mimicry allowing the bacterium to hide from the immune system by blending in with the gastric epithelia12,13. LPS is a biomolecule consisting of lipid and polysaccharide located in the outer membrane of Gram-negative bacteria. Helicobacter pylori LPS plays a synergistic role with OMPs in binding to host gastric cells. Inhibition of LPS carbohydrate determinants has been shown to affect adherence of clinical isolates of H. pylori to human cells in culture14,15.
Helicobacter pylori LPS structure includes lipid A, core-oligosaccharide, and O antigen16. The O antigen contains a glucan group, a DD-heptan group and a highly conserved “trio” trisaccharide16,17. Variability of LPS occurs between strains, and due to bacterial phase variation, whereby H. pylori uses an on/off environmental sensor system to regulate biosynthetic genes that alter carbohydrate expression of the O antigen18. Several studies have examined the molecular structure of H. pylori glycans and LPS12,16,19,20. One such study used agglutination techniques to identify lectin reactivity, while another utilised a lectin microarray14,19. Silva et al.19 identified Lex and Ley as well as N-acetyllactosamine determinates on all H. pylori clinical isolates tested. Additionally, 1,3-d-galactans and blood group H-type 2 antigens were identified in some clinical isolates19. Chionh et al.14 examined if carbohydrates can inhibit binding H. pylori to human cell lines. Mannose, N-acetylgalactosamine, N-acetylglucosamine, fucose and sialic acid were significantly more effective at inhibiting cellular binding of H. pylori clinical isolates compared to mouse adapted strains14. The structural diversity and variation of the H. pylori LPS presents a challenge in establishing an accurate structure–function relationship between the H. pylori LPS and an infected host. Further structural studies can provide a better picture of the underlying molecular interactions of the H. pylori LPS as a part of its role in pathogenesis19. Additionally, the H. pylori LPS appears to play an important role in the adhesion of the bacteria to gastric cells, with disruption of the LPS significantly reducing the organism’s adhesion to gastric cells21.
The ability of atomic force microscopy (AFM) to measure mechanical and adhesive properties facilitates the characterisation of surface properties of microbial cells22,23,24,25,26. The peptidoglycan layer of live microbes such as Escherichia coli and Pseudomonas aeruginosa have been previously investigated using AFM in aqueous conditions27. AFM has also been used to measure the biophysical properties of bacteria such as H. pylori allowing for a deeper understanding of surface adhesion that can be applied to other protein-carbohydrate interactions for assessment in drug discovery28. For H. pylori specifically, AFM has been used to look at interactions between Leb and H. pylori blood group binding adhesin (BabA). Based on the complexity of the interaction, Parreira et al. proposed a two-step model for ligand binding for the BabA-Leb complex29.
This study aimed to profile glycans expressed by H. pylori using lectins and monoclonal antibodies (mAbs). The H. pylori strains SS1 and 26695 were selected as their glycans were expected to be adapted for efficient colonisation of mouse and human hosts, respectively. Proteins found to bind H. pylori were used in AFM experiments to directly measure the interactions of these proteins with H. pylori 26695. AFM was demonstrated to be useful in probing direct interactions between H. pylori 26695 and human gastric adenocarcinoma cells (AGS). Furthermore, antibody-binding to Ley determinants in H. pylori 26695 LPS can reduce bacterial adhesion to AGS cells.
Materials
Immunofluorescence and ELISA
Lectins used for primary staining (Table 1) were from the biotinylated Lectin Kit 1 (BK-1000) and biotinylated Lectin Kit 2 (BK-2100) (Vector laboratories) and were used at a concentration of 10 μg/mL.
The lectins used for immunofluorescence were Fluorescein Lectin Kit I (FLK-2100) and Fluorescein Lectin Kit II (FLK-3100) supplied by Vector laboratories. The panel of mAbs tested included FG27 and ch88.2 provided by Professor Lindy Durrant (Scancell UK, University of Nottingham UK), 15.101 provided by Emeritus Professor Mauro Sandrin (University of Melbourne, Australia), mu58 and mu3S193 provided by Professor Andrew Scott (ONJCRI), and 7LE, 2-25LE and LWY/1463 (Table 2) purchased from Abcam (Cambridge, UK). A nuclear stain (4′,6-diamidino-2-phenylindole, DAPI, Sigma/Merck) was used to ensure the presence of bacteria on the slide. The same mAbs used were for immunofluorescence and ELISA. All ELISAs were performed on 96-well NUNC plates (ThermoFisher, USA). The secondary antibodies used included goat anti-mouse IgG HRP ab6789 (abcam, USA) and goat anti-human IgG Fc secondary antibody HRP (ThermoFisher, USA) for ELISA, and goat anti-mouse IgG Alexa Fluortm 488 (ThermoFisher, USA) and goat anti-human IgG cross-absorbed secondary antibody Alexa Fluortm 488 (ThermoFisher, USA) for immunofluorescence. NeutrAvidin protein HRP (ThermoFisher, USA) was used for the detection of lectin binding.
Atomic force microscopy
AFM was performed using a JPK nanowizard 4 (JPK BioAFM Business, Am Studio 2D, 12489 Berlin, Germany) using AFM RESPA-10 probes (Bruker, USA, nominal spring constant kc = 0.1 N/m, nominal tip radius 8 nm, rectangular geometry, nominal cantilever length and width 45 µm and 5 µm, respectively, nominal resonance frequency 10 Hz) and tipless cantilevers AIO-TL-50 (Budget Sensors, USA—nominal spring constant = 0.2 N/m, nominal cantilever length and width 500 µm and 30 µm, nominal resonance frequency 15kHz) with fluorodish® (WPI, USA) glass bottomed petri dishes, thinly coated with poly-d-Lysine. AFM force measurements were obtained using a JPK nanowizard 4 (JPK BioAFM Business, Am Studio 2D, 12489 Berlin, Germany) operated in a liquid environment. Adhesion values were measured from the retraction profile of each force curve taking the minimum value of each profile, typically a negative value, which is then converted into a positive value to elucidate adhesive force. AFM data were processed using a combination of JPK software (https://www.jpk.com/), which allowed for the extraction of the single point adhesion measurements, and the Gwyddion 2.50 software package, which allowed for the processing of the AFM images and the extraction of the data for the percent frequency and cross section graphs.
Methodology
Helicobacter pylori culture and preparation of lysate
Helicobacter pylori strains SS1 (ATCC 43504) and 26695 (ATCC 700392) were revived from glycerol stocks and cultivated under microaerophilic conditions at 37 °C for 48–72 h on lysed horse blood agar (HBA). Bacteria were harvested and cultured overnight in 10 mL of brain heart infusion (BHI) broth supplemented with 10% heat-inactivated FCS (ThermoFisher, USA) (shaker incubator at 150 rpm, 37 °C). Bacteria were harvested by centrifugation and washed with 2 mL of phosphate buffered saline (PBS) and centrifuged at 5000 rpm for 10 min. The cells were then resuspended in 2 mL PBS and disrupted using microbeads and sonication. The presence and integrity of H. pylori proteins in the lysate of both strains was confirmed via gel electrophoresis and the lysate was then stored at − 80 °C.
ELISA
The H. pylori lysate at a protein concentration of 10 µg/mL in carbonate–bicarbonate buffer pH 9.2 was used to coat the wells of 96-well NUNC plates. The ELISA was performed using a direct ELISA protocol; wells were blocked using 0.5% (m/v) poly(vinyl alcohol) for lectins and 1% goat serum for mAbs, and then incubated for 1 h at 37 °C and washed four times with tris-buffered saline (TBS) 0.05% Tween 20 (TBST) before testing with the panel of lectins and mAbs. After lectins and mAbs were added, the plate was incubated for an hour at 37 °C and washed four times with TBST. The secondary antibody for mAbs (goat anti-mouse IgG (abcam)) was added and the plate was incubated for 30 min at 37 °C, then washed again. Finally the substrate, 2,2-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt (ABTS), was added developed at room temperature for 20 min. A pool of serum from mice that had been vaccinated against H. pylori33 was used as positive control, and a pool of serum from naive mice as a negative control. Each lectin and mAb was tested in four replicates over three separate ELISA tests.
Immunofluorescence
Bacteria cultured from HBA plates were heat fixed onto Superfrost Plus glass slides (Thermo Fisher) for immunofluorescence (IF). IF was performed using a standard direct IF procedure. Slides were blocked with 1% goat serum for 20 min, then washed 3 times with PBS before addition of mAbs. The slides were incubated for 30 min and washed with PBS. The secondary (Alexa Fluor® 488) antibody was added and incubated for a further 30 min and the wash was repeated. Slides were counterstained with DAPI to visualise bacterial cells on the slides via detection of bacterial nucleic acid. A similar procedure was also used for lectins, with the addition of FITC-labelled lectins instead of mAbs, the slides were then incubated for 30 min and washed three times with PBS and counterstained with DAPI.
AFM of bacterial cells
Helicobacter pylori 26695 was retrieved from solid culture and suspended in 1 mL PBS. Bacterial suspensions were incubated for 1 h at room temperature (RT) in a fluorodish® (WPI, USA) glass bottomed petri dish thinly coated with poly-d-Lysine, to allow attachment of H. pylori to the glass. Plates were then washed 3 times with PBS and re-wetted with 2 mL of PBS for probing in liquid. AFM RESPA-10 probes were treated by overnight incubation in either a 2 mg/mL solution of WGA or a 2 μg/mL solution of anti-Ley (mu3S193) in PBS at 4 °C. The treated cantilever was then washed in PBS for 1 h at room temperature before use. JPK nanowizard 4 was operated in QI mode for all bacterial imaging experiments. QI mode allows for the successive collection of force vs distance curves, obtaining an individual force curve for each pixel. This provides height, adhesion and elasticity data for each individual location probed. RESPA-10 probes were used for all experiments and each cantilever was tuned using the thermal spectrum method. Images were collected at rates of 1.8–25.7 Hz with the rate of each collection adjusted to reduce background noise. The approach and retraction speeds were similarly adjusted and ranged between 175 and 240 μm/s over Z distances of 5–20 μm, with final images typically collected at 6–8 μm, at 128 × 128 pixels per frame. Set point values to ensure engagement of the cantilever typically fell between 1 and 3 nN of force.
AFM of AGS cells
AGS cells (CRL-1739) were grown in RPMI 1640 medium (ThermoFisher, USA) with 10% foetal calf serum (FCS, ThermoFisher, USA) and 1% penicillin–streptomycin (ThermoFisher, USA) at 37 °C with 5% CO2 to 70% confluence and incubated on a fluorodish® overnight prior to measurement and used for AFM imaging within 4 h. Helicobacter pylori 26695 coated AIO-TL-50 tipless cantilevers were first incubated with polydopamine for 1 h and then pressed 3 times for 20-min intervals against a H. pylori 26695 prepared fluorodish® as described above, allowing for the H. pylori 26695 cells to coat the cantilever. AGS cells were first imaged with QI mode in the same manner as the above bacterial experiments and then adhesion measurements were taken using single point spectrometry with a retraction of 5 µm and were pressed against the cells for 10 s intervals.
Statistical analysis and figure generation
All graphs and statistical data were stored and processed using GraphPad prism 9.5.0/10.0.0 and Microsoft Excel. IF images were captured using the DM 2500 Leica Fluorescence Microscope and processed using a combination of the Leica Aperio Laboratory Information Systems (LIS), Adobe Photoshop 2022 and ImageJ. Adobe Photoshop 2022 was also used to combine AFM images processed in Gwyddion 2.50 into figures.
Results
ELISA and immunofluorescence were performed to characterise the glycan profile of H. pylori SS1 and 26695. Previous studies have identified the presence of Lewis antigens on H. pylori, although the exact Lewis type can vary between isolates. Additionally, of the lectins to be screened, only WGA and UEA had previously shown reactivity via agglutination assays14,20. For this study, we characterised a broader and different range of carbohydrates to previous studies and characterised the specific Lewis antigens present on the isolates of H. pylori SS1 and 26695.
Helicobacter pylori SS1 displays a broader range of carbohydrates than 26695
The glycans present in lysates of H. pylori (SS1 and 26695) were examined by ELISA against 18 lectins (Fig. 1). The SS1 lysate interacted strongly with 6 lectins including wheat germ agglutinin (WGA), concanavalin A (Con A), Elder bark lectin (EBL), Phaseolus vulgaris erythroagglutinin (PHA-E), and Pisum sativum agglutinin (PSA). This reactivity of lectins suggests the presence of glycans containing N-acetylglucosamine, mannose, sialic acid, and complex N-type glycans in the bacterial lysate of H. pylori SS1. Strain 26695 showed similarities to SS1, with both strains of H. pylori possessing N-acetylglucosamine and mannose based on the WGA and Con A binding. Interestingly, a wider array of lectin binding and higher absorbance values were observed for the SS1 strain compared to the 26695 strain. This finding suggests a wider glycan expression profile for SS1 in comparison to 26695. The intensity of the binding of serum pool A for H. pylori 26695 lysate was reduced in ELISA in comparison to the SS1 lysate. This probably reflects that the mice had been challenged with the mouse-adapted SS1 strain34 and therefore are likely to have had a more specific antibody response to the challenge strain.
WGA and Con A interact with H. pylori SS1 and 26695 via Immunofluorescence and ELISA
Immunofluorescence staining using 18 FITC-labelled lectins against the SS1 strain revealed binding of sWGA, WGA and Con A on whole bacterial cells indicating the presence of N-acetylglucosamine and mannose on the bacterial surface (Fig. 2A). These results are similar to those obtained by ELISA; however, there were some key differences: the lectin PHA-E showed no reactivity against SS1 by IF (Fig. S1), and sWGA, which binds N-acetylglucosamine, showed reactivity via IF but did not show reactivity by ELISA. Note that sWGA did not bind to the lysate in ELISA, which is unusual since it binds to a similar glycan to WGA (which showed strong binding by ELISA). However, WGA is suggested to bind weakly to sialic acids, as well as N-acetylglucosamine, while sWGA does not, which is a possible explanation for the difference in binding seen here. PSA, PHA-E, and EBL did not show binding via IF but were positive in ELISA, indicating that these lectins may bind to internal polysaccharides which are exposed when the cells are lysed. Figure 2B shows the lectin IF assay of 26695, which is relatively consistent with the results obtained with SS1. The lectins Con A, WGA, and sWGA were found to interact with H. pylori 26695, although the binding of Con A was less specific than what was seen against SS1. The increased binding seen to SS1 in comparison with 26695 via the ELISA was less apparent in the IF. This may be a result of the limitation of the method in terms of quantification, as possible differences between the lysates used to prepare the ELISAs make direct comparison difficult, or it may be that SS1 has more internally expressed glycans which are not revealed by immunofluorescence on intact bacteria.
Reactivity of mAbs and against H. pylori SS1 and 26695 via ELISA
Compared to lectins, mAbs generally recognise larger carbohydrate determinants and are generally more specific. Thus, we next examined the binding of H. pylori glycans with a panel of carbohydrate-binding mAbs. Of the mAbs tested, FG27, a mouse anti-Ley IgG and 15.101, a mouse anti-αGal IgG showed reactivity against H. pylori SS1 via ELISA (Fig. 3). Three different anti-Ley mAbs were shown to bind to the two H. pylori strains tested. The other anti-Lewis mAbs used did not show any indication of binding against H. pylori SS1 or 26695, indicating the isolates tested possess the Lewis Y antigen.
Reactivity of mAbs against H. pylori SS1 and 26695 in immunofluorescence
The pattern of binding of the mAbs in IF was very similar to the results from the ELISA screen. For SS1 (Fig. 4A), the anti-Ley mAbs bound to the bacteria and the anti-αGal mAb 15.101 also bound, although 15.101 appeared to have low reactivity in IF. Lea/Lex and Leb binding mAbs were also tested and showed no reactivity (Fig. S2). The binding pattern of Lewis antigen specific mAb to the 26695 strain (Fig. 4B) was also mostly consistent with both the ELISA and with the SS1 results. The binding of anti-Ley mAbs to 26695 also indicates the presence of the Lewis Y antigen on this strain of H. pylori. The anti-αGal 15.101 showed almost no reactivity to 26695 via IF, indicating that the αGal determinants are mostly on intracellular glycoconjugates for this laboratory strain.
Adhesion of mAbs and lectins measured using force spectrometry
Based on the results of the lectin and antibody screening, WGA and anti-Ley antibodies were selected for AFM studies to investigate binding interactions with glycans on intact and viable H. pylori cells. AFM tips were functionalised by adsorption of either antibody or lectin to the tip and used to image H. pylori 26695. Data collected with functionalised AFM probes were then compared to data obtained using an uncoated tip. Anti-Ley (mu3S193) and WGA were selected to be tested with the AFM technique based on the previously observed consistent binding in the immunoassays. The AFM is able to simultaneously measure the height of the bacterium against a flat background, and the adhesive force between the molecules used to functionalise the tip and the bacterium.
Figure 5 shows AFM images and force profiles conducted with cantilevers functionalised with anti-Ley and WGA, as well as untreated (as received) cantilevers. Here, images are produced in QI mode, which uses progressive force-mapping of the interface—The AFM tip is moved towards (approach) and away (retract) from the sample producing an image from the point of contact at each discreet X–Y surface location, while simultaneously collecting a force curve at each discreet location on the sample. This supplies topological (height) profiles of the interface (see Fig. 5A), as well as adhesion maps (see Fig. 5B). Tip-sample adhesion is measured in an AFM force profile as the minima of the force upon retraction from the sample, which represents the maximum force needed to remove the tip from the sample. Adhesion is observed in the retraction curve of an AFM force profile, as attractive forces between the AFM tip and the sample surface result in a negative force, reflecting the energy required to overcome molecular interactions during the separation of the tip and the sample. This force is then converted to a positive force of adhesion. This allows the measurement of the force (nN) of the binding events (Fig. 5C, minima highlighted by a circle). Together these measurements provide nanoscale detail of the adhesive interactions between antibodies or lectins and glycans present on H. pylori 26695. Adhesion events could be measured with functionalised tips but not with untreated tips. The anti-Ley coated tip showed increased adhesion predominantly on and around the sides of the cells while WGA typically showed binding over the entire surface of the bacteria (Fig. 5B). Again, only the carbohydrate-binding protein coated cantilevers showed adhesion to the bacterial surfaces.
A cross section of adhesion data for a single bacterial cell was made for the anti-Ley and WGA treated tips in comparison to an untreated tip (Fig. 6). These were able to demonstrate the increase in adhesion of both the lectin and mAb over the surface of the bacterial cell, where in comparison a plain AFM tip shows a reduction in adhesion over the softer surface of the bacterial cell. Furthermore, the height measurement was used to extract the adhesion event percentage frequencies across only bacterial cells. This allowed for a direct comparison of the force data between the treated tips and the untreated tip. Both treated tips displayed multiple adhesion events greater than 1.5 nN, in comparison to the untreated tip which had over 90% of readings below 0.5 nN and all readings were 1.0 nN and below. This result was reproducible with both anti-Ley and WGA treated tips used on 3 separate occasions. The increase in the overall adhesion and the spike in adhesion events allow us to map the expression of the carbohydrates on the surface of the bacterial cell. Particularly the wider distribution of N-acetylglucosamine across the surface of the cell can be seen via the WGA adhesion while Ley can be seen around the edges of the cell in localised areas. This finding likely reflects a different surface distribution of Ley determinants when compared to glycans containing N-acetylglucosamine residues.
Following the adhesion experiments with WGA and anti-Ley, we performed blocking studies to confirm the specificity of binding. For WGA, a 100 mM solution of N-acetylglucosamine was added to the liquid bacterial suspension at a 1:1 dilution (for a final N-acetylglucosamine concentration of 50 mM) and incubated for 30 min before screening. This process was repeated for anti-Ley using a 100 mM solution of the Lewis Y tetrasaccharide (final concentration 50 mM). In both cases, the glycan solutions blocked the adhesion from the treated tip, greatly reducing the adhesion of the tip across the surface of the bacteria (Fig. S3). WGA exhibited higher background binding than the anti-Ley mAb, however it was still overall lower than the unblocked lectin over the surface of the bacteria (Fig. S4).
Blocking Ley with mAb reduces H. pylori adhesion to AGS cells
Once we had established the adhesion of anti-Ley to H. pylori 26695 could be measured with AFM, we sought to demonstrate the adhesion of H. pylori 26695 to human gastric cells (AGS cells) and examine if the adhesion could be reduced by binding an anti-Ley mAb to H. pylori. Figure 7 shows the AFM scan of AGS cells using a cantilever coated with H. pylori 26695 using polydopamine, in comparison to a plain AFM cantilever. The adhesion of the bacteria around the edges and towards the centre of the AGS cell can be clearly seen in comparison to the plain tip, which shows a reduction in adhesion over the softer cell surface.
A tipless AFM cantilever was then used to take adhesion measurements of H. pylori 26695 under three conditions. The first of which was the AFM cantilever coated with H. pylori 26695. Second, was using a cantilever coated only with polydopamine as a control. And finally, a cantilever coated with H. pylori 26695, that had been incubated with anti-Ley for approximately 30 min. This was done to allow us to explore the potential of carbohydrate binding proteins to block the adhesion of H. pylori 26695 to AGS cells. In Fig. 8A a histogram of the adhesion under the three conditions can be seen, with the H. pylori coated cantilever displaying the highest adhesion of the three conditions (maximum ~ 0.85 nN), and with that the addition of anti-Ley significantly reducing bacterial adhesion to the AGS cells (maximum 0.55 nN). Figure 8B shows a statistical comparison between the three conditions via one-way ANOVA, with a significant reduction in the mean adhesion of H. pylori 26695 to AGS cells on the addition of anti-Ley, indicating the ability of the carbohydrate binding mAb to interfere with bacterial adhesion.
Discussion
Glycan expression by H. pylori is thought to play a role in both infection and evasion of the host immune system35,36. Helicobacter pylori has a known association to the Lewis tissue and histo-blood group antigens. Firstly, through adhesion proteins BabA and SabA which bind to Lewis antigens37, and secondly, through expression of Lewis determinants in H. pylori LPS that mimic Lewis antigens of the host, suggesting a role of these antigens in bacterial immune evasion16,38. Previous studies have characterised the glycan composition of the H. pylori LPS by molecular methods, structural methods, and immunological assays such as glycan microarrays and agglutination assays14,19. In a previous lectin microarray investigation, WGA, Con A, and RCA were shown to bind to the H. pylori 26695 strain39. Due to the complex role of glycans in H. pylori infection further studies are needed to better understand their role in the host–pathogen interaction. Some previous studies have looked at adhesion of bacterial cells using AFM, with El-Kirat-Chatel et al. using antibody treated tips to study Pseudomonas fluorescens large adhesion protein (LapA) and the relationship of said protein to the formation of biofilms, with LapA footprints recorded to be 50–600 pN40. Another study by Herman-Bausier et al. examined the adhesion of Staphylococcus aureus collagen binding protein Cna which demonstrated binding forces of ~ 1.2 nN to collagen, which was disrupted by multiple mAbs, including 9G7, C2 and 11H1141. Some studies have explored using AFM to measure bacterial glycan interactions with mAbs, lectins42,43,44, and, with regard to H. pylori, Parreira et al. demonstrated the mechanistic binding method between H. pylori blood-group binding adhesin (BabA) and Lewis B29. Parreira et al. also highlighted the potential for AFM in the development of new targeted therapies against bacteria28. As H. pylori glycans are known to play a role in bacterial adhesion to human cells, further exploration of how to interrupt glycan expression and binding by H. pylori may provide new targets for therapeutic development.
In this study, lectins, and glycan/Lewis targeting antibodies were used to profile the glycans of H. pylori strains SS1 and 26695 using ELISA with bacterial lysates, and IF on intact bacteria. Additionally, the interactions of anti-Ley mAb and WGA with H. pylori were examined using AFM and followed up by the examination of the direct interaction between H. pylori 26695 and AGS cells. Furthermore, adhesion was shown to be disrupted by antibody-targeting of bacterial surface carbohydrates. The H. pylori LPS has been previously found to express a number of different structures, including an array of Lewis determinates at its nonreducing end38. In our study, WGA, Con A and anti-Ley mAbs showed reactivity in both ELISA and IF, and sWGA showed reactivity in IF. The sialic acid recognising EBL was found to bind 26695 in ELISA. Helicobacter pylori has been previously found to interact with sialyl-Lex antigens via the sialic acid binding adhesin (SabA), and glycosylation of N-acetylglucosamine (GlcNAc) structures with sialic acid or fucose residues10,45,46. Here, the 15.101 mAb, which binds to galactose-α1,3-galactose containing glycans was found to interact with 26695 in ELISA47. Notably, neither EBL nor 15.101 mAb showed reactivity in IF assays, which could possibly be explained by a difference in sensitivity between the two assays48. Alternatively, lack of binding in IF may suggest that the target glycans are internal and not displayed on the bacterial surface.
The lectin sWGA showed reactivity by IF but not by ELISA, and it is possible that the GlcNAc structure recognised by sWGA is disturbed during the lysis process or that it is present in low abundance. In the case of H. pylori SS1, WGA, ECA and UEA all bound in the ELISA and had been previously identified49,50,51. Con A also bound to SS1 glycans in both assays which is consistent with results for 26695. This differs from a previous study, where agglutination assays could not demonstrate a Con A interaction with SS114. However, Con A interaction has been reported for clinical isolates of H. pylori, and it is possible that differences in assay sensitivities explain the observed differences39,52,53. Notably, several additional lectins were found to interact with SS1 compared to 26695, including PSA, which binds mannose, PHA-E, which binds biantennary glycosylated N-glycan bisecting GlcNAc, and EBL which binds sialic acid54,55,56. Most of these additional lectins that bound in ELISA did not bind via IF suggesting that these glycan targets are internal rather than displayed on the bacterial surface57. This may be the case for stored sugars, those currently undergoing biosynthesis, or may involve glycosylated proteins and enzymes58. Interestingly, mass spectrometry has revealed that H. pylori possess a vast array of glycoproteins expressed in different locations, including the cytoplasm, periplasm, and inner cell membrane, with as many as 52% of these glycoproteins expressed in the cytoplasm59.
The 15.101 mAb, an anti-αGal30, bound both in ELISA and IF for SS1 but appeared to have some background staining in the IF assay. In the case of SS1, while an αGal antibody has not been tested with SS1 before, lectin BS-I, which binds to αGal, was found to interact with SS1 in agglutination assays14. A previous study has also found that 26695 has a reduced variety of carbohydrate expression in comparison to clinical isolates50. Additionally, the difference in ELISA and immunofluorescence results, even within the same strain, highlights the likely differences that can be seen between internally and externally expressed glycan epitopes. While these observations have been raised previously57, they are important to note when profiling glycan expression.
AFM was used to image H. pylori and the nanoscale scans revealed the spiral bacillus morphology of the bacterium. A degree of pleomorphy was observed, as has previously been seen in H. pylori in light microscopy60. Bacterial flagella could only be sporadically seen on the scans, likely due to the regulation of flagella expression by H. pylori on solid media61. The AFM analysis also provided a large quantity of force data, allowing determination of the interaction between H. pylori, and anti-Ley and WGA. Anti-Ley could be seen to interact with H. pylori along the sides of the bacteria and on flagella-like objects where those could be seen, with the force of adhesion ranging between 1 and 2.5 nN (Fig. 5A). The adhesion pattern observed for WGA indicates more surface area of the bacteria was coated with N-acetylglucosamine glycans, with WGA:glycan adhesion forces ranging between 1 and 2 nN. This contrasts with measurements taken with the nontreated AFM tip, which frequently showed lower adhesion than the background and had no data points over 1 nN (Fig. 6).
In this study, we also explored the ability of mAbs against carbohydrates to block adhesion of bacteria to stomach cells. We observed a significant reduction in adhesion of H. pylori 26695 to AGS cells after binding of an anti-Ley mAb to a bacteria-coated tip, which reduced the mean adhesion by 0.16 nN and the maximum adhesion by 0.29 nN. This finding supports the potential of carbohydrate targets for future development of therapeutics for H. pylori infection. The work presented here differs from previous AFM studies on H. pylori and is the first study focusing on the characterisation and quantification of antibody-glycan interactions and blocking with an anti-Ley mAb of H. pylori 26695 adhesion to AGS cells in vitro.
While the current investigation focuses on the surface glycans and targeting of H. pylori with Ley binding antibodies, the glycan-mediated host interactions are complex. Effective in vivo blocking of H. pylori interactions with gastric mucosa and gastric epithelial cells will need to consider several factors. As previously mentioned, H. pylori has several carbohydrate binding OMPs that are involved in gastric adhesion. The most predominant of these, BabA, binds to the Leb and H1 blood group antigens. Glycan recognition by BabA is mediated by a terminal α1,2 linked fucose (Fuc) on a Galβ1-3GlcNAc core, allowing it to commonly adhere to Leb positive epithelial cells and MUC-5AC in the mucosa62,63. Notably, BabA does not bind to Lea that lacks an α1,2-linked Fuc residue5. Furthermore, loss of fucosyltransferase 2 (FUT2) or non-secretion of Leb impairs the adherence of the bacteria to the gastric mucosa64. However, H. pylori possess other non-BabA mediated methods of adhesion, and expression of BabA may be modified by changing gastric conditions, and is lost entirely in some animal models37. The SabA protein binds preferentially to SLex, but also binds to SLea37,65. These glycans are minimally expressed in the gastric epithelium and mucosa in healthy individuals, but are upregulated in inflammatory and cancerous states, leading to the suggestion that SabA is important in chronic infection7. Helicobacter pylori may also play a role in the regulation of expression of host glycans in chronic infection 66. Another important OMP is HopQ, which binds carcinoembryonic antigen-related cell adhesion molecules (CEACAMs)67. In relation to HopQ specifically, CEACAM1, CEACAM5 and CEACAM6 are all upregulated in gastritis caused by chronic H. pylori infection, again suggesting a mechanism for H. pylori promoting its own persistence in an inflammatory environment67,68. Additionally, the LacdiNAc binding adhesin (LabA) or HopZ plays a potential supporting role in binding to MUC-5AC69 and the proteins AlpA and AlpB display a role in binding to host laminin70.
A motivation for this study, is H. pylori LPS has been shown to play a significant role in adhesion, and H. pylori mutants with truncated LPS exhibited reduced adhesion to AGS cells21. Helicobacter pylori employs a generalized two-step system for the glycosylation of adhesion proteins such as BabA, utilizing similar enzymes to what are responsible to LPS biosynthesis, with disruption of this process resulting in a loss of bacterial adhesion in vitro71. The complexity of the mechanisms of adhesion of H. pylori underlines the significance for the survival and persistence of the bacterium. Interference of H. pylori interactions with gastric carcinoma cells by monoclonal antibodies specific for Ley glycans as demonstrated here is one further step in understanding the complex roles of carbohydrates in bacteria–host interactions.
Conclusion
This study explored glycan-protein interactions of two model H. pylori laboratory strains and examined the molecular adhesion of lectin WGA and anti-Ley to H. pylori 26695 using AFM. We have identified several glycan-binding proteins that interact with two reference strains of H. pylori, highlighting the differences in glycan expression between these strains and emphasising the usefulness of AFM force spectroscopy in measuring the interactions between anti-glycan proteins and target ligands on live bacterial cells. Furthermore, this study demonstrated a reduction in H. pylori adhesion to AGS cells via carbohydrate-targeting antibodies, successfully blocking adhesion of H. pylori 26695 to AGS cells after incubation with anti-Ley mAb via AFM measurements.
Data availability
All data are included in the Supplemental Information or available from the corresponding author upon reasonable request. The raw numbers for charts and graphs are available in the Source Data file provided with this paper.
References
Hatakeyama, M. Malignant Helicobacter pylori-associated diseases: Gastric cancer and MALT lymphoma. Adv. Exp. Med. Biol. 1149, 135–149. https://doi.org/10.1007/5584_2019_363 (2019).
Testerman, T. L. & Morris, J. Beyond the stomach: An updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J. Gastroenterol. 20, 12781–12808. https://doi.org/10.3748/wjg.v20.i36.12781 (2014).
Ruggiero, P. Helicobacter pylori and inflammation. Curr. Pharm. Des. 16, 4225–4236. https://doi.org/10.2174/138161210794519075 (2010).
Mungazi, S. G., Chihaka, O. B. & Muguti, G. I. Prevalence of Helicobacter pylori in asymptomatic patients at surgical outpatient department: Harare hospitals. Ann. Med. Surg. (Lond.) 35, 153–157. https://doi.org/10.1016/j.amsu.2018.09.040 (2018).
Borén, T., Falk, P., Roth, K. A., Larson, G. & Normark, S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262, 1892–1895. https://doi.org/10.1126/science.8018146 (1993).
Ilver, D. et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279, 373–377. https://doi.org/10.1126/science.279.5349.373 (1998).
Mahdavi, J. et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297, 573–578. https://doi.org/10.1126/science.1069076 (2002).
Hage, N. et al. Structural basis of Lewis(b) antigen binding by the Helicobacter pylori adhesin BabA. Sci. Adv. 1, e1500315–e1500315. https://doi.org/10.1126/sciadv.1500315 (2015).
Benktander, J., Barone, A., Johansson, M. M. & Teneberg, S. Helicobacter pylori SabA binding gangliosides of human stomach. Virulence 9, 738–751. https://doi.org/10.1080/21505594.2018.1440171 (2018).
Matos, R. et al. Adhesion of Helicobacter species to the human gastric mucosa: A deep look into glycans role. Front. Mol. Biosci. 8, 656439–656439. https://doi.org/10.3389/fmolb.2021.656439 (2021).
Wirth, H.-P. et al. Host Lewis phenotype-dependent Helicobacter pylori Lewis antigen expression in rhesus monkeys. FASEB J. 20, 1534–1536. https://doi.org/10.1096/fj.05-5529fje (2006).
Li, H. et al. Lipopolysaccharide structure and biosynthesis in Helicobacter pylori. Helicobacter 21, 445–461. https://doi.org/10.1111/hel.12301 (2016).
Chmiela, M. & Kupcinskas, J. Review: Pathogenesis of Helicobacter pylori infection. Helicobacter 24(Suppl 1), e12638–e12638. https://doi.org/10.1111/hel.12638 (2019).
Chionh, Y.-T., Walduck, A. K., Mitchell, H. M. & Sutton, P. A comparison of glycan expression and adhesion of mouse-adapted strains and clinical isolates of Helicobacter pylori. FEMS Immunol. Med. Microbiol. 57, 25–31. https://doi.org/10.1111/j.1574-695X.2009.00578.x (2009).
Odenbreit, S. Adherence properties of Helicobacter pylori: Impact on pathogenesis and adaptation to the host. Int. J. Med. Microbiol. 295, 317–324. https://doi.org/10.1016/j.ijmm.2005.06.003 (2005).
Li, H. et al. The redefinition of Helicobacter pylori lipopolysaccharide O-antigen and core-oligosaccharide domains. PLoS Pathog. 13, e1006280–e1006280. https://doi.org/10.1371/journal.ppat.1006280 (2017).
Li, H. et al. Lipopolysaccharide structural differences between Western and Asian Helicobacter pylori strains. Toxins (Basel) 10, 364. https://doi.org/10.3390/toxins10090364 (2018).
Nilsson, C. et al. An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection. Proc. Natl. Acad. Sci. U.S.A. 103, 2863–2868. https://doi.org/10.1073/pnas.0511119103 (2006).
Silva, L. M. et al. Helicobacter pylori lipopolysaccharide structural domains and their recognition by immune proteins revealed with carbohydrate microarrays. Carbohydr. Polym. 253, 117350. https://doi.org/10.1016/j.carbpol.2020.117350 (2021).
Monteiro, M. A. et al. Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl Lewis X, and H. pylori UA915 expressing Lewis B classification of H. pylori lipopolysaccharides into glycotype families. Eur. J. Biochem. 267, 305–320. https://doi.org/10.1046/j.1432-1327.2000.01007.x (2000).
Chang, P.-C., Wang, C.-J., You, C.-K. & Kao, M.-C. Effects of a HP0859 (rfaD) knockout mutation on lipopolysaccharide structure of Helicobacter pylori 26695 and the bacterial adhesion on AGS cells. Biochem. Biophys. Res. Commun. 405, 497–502. https://doi.org/10.1016/j.bbrc.2011.01.060 (2011).
Sijmons, D. et al. In Methods in Microbiology Vol. 54 (ed. Gűrtler, V.) 36 (Elsevier, 2023).
Cheeseman, S. et al. Interactions between liquid metal droplets and bacterial, fungal, and mammalian cells. Adv. Mater. Interfaces 9, 2102113. https://doi.org/10.1002/admi.202102113 (2022).
Penman, R. et al. Gold nanoparticle adsorption alters the cell stiffness and cell wall bio-chemical landscape of Candida albicans fungal cells. J. Colloid Interface Sci. 654, 390–404. https://doi.org/10.1016/j.jcis.2023.10.017 (2024).
Pham, D. Q. et al. Micro- to nano-scale chemical and mechanical mapping of antimicrobial-resistant fungal biofilms. Nanoscale 12, 19888–19904. https://doi.org/10.1039/D0NR05617K (2020).
Dufrêne, Y. F., Viljoen, A., Mignolet, J. & Mathelié-Guinlet, M. AFM in cellular and molecular microbiology. Cell. Microbiol. 23, e13324. https://doi.org/10.1111/cmi.13324 (2021).
Yao, X., Jericho, M., Pink, D. & Beveridge, T. Thickness and elasticity of gram-negative murein sacculi measured by atomic force microscopy. J. Bacteriol. 181, 6865–6875. https://doi.org/10.1128/jb.181.22.6865-6875.1999 (1999).
Parreira, P. & Martins, M. C. L. The biophysics of bacterial infections: Adhesion events in the light of force spectroscopy. Cell Surf. 7, 100048. https://doi.org/10.1016/j.tcsw.2021.100048 (2021).
Parreira, P. et al. Atomic force microscopy measurements reveal multiple bonds between Helicobacter pylori blood group antigen binding adhesin and Lewis b ligand. J. R. Soc. Interface 11, 20141040. https://doi.org/10.1098/rsif.2014.1040 (2014).
Agostino, M., Sandrin, M. S., Thompson, P. E., Yuriev, E. & Ramsland, P. A. Identification of preferred carbohydrate binding modes in xenoreactive antibodies by combining conformational filters and binding site maps. Glycobiology 20, 724–735. https://doi.org/10.1093/glycob/cwq022 (2010).
Soliman, C. et al. Molecular and structural basis for Lewis glycan recognition by a cancer-targeting antibody. Biochem. J. 477, 3219–3235. https://doi.org/10.1042/bcj20200454 (2020).
Kitamura, K. et al. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Proc. Natl. Acad. Sci. U.S.A. 91, 12957–12961. https://doi.org/10.1073/pnas.91.26.12957 (1994).
Aebischer, T. et al. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 57, 1065–1072. https://doi.org/10.1136/gut.2007.145839 (2008).
Becher, D. et al. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice. Eur. J. Immunol. 40, 2778–2790. https://doi.org/10.1002/eji.200940219 (2010).
Moran, A. P. Lipopolysaccharide in bacterial chronic infection: Insights from Helicobacter pylori lipopolysaccharide and lipid A. Int. J. Med. Microbiol. 297, 307–319. https://doi.org/10.1016/j.ijmm.2007.03.008 (2007).
Abadi, A. T. B. Strategies used by Helicobacter pylori to establish persistent infection. World J. Gastroenterol. 23, 2870–2882. https://doi.org/10.3748/wjg.v23.i16.2870 (2017).
Doohan, D., Rezkitha, Y. A. A., Waskito, L. A., Yamaoka, Y. & Miftahussurur, M. Helicobacter pylori BabA-SabA key roles in the adherence phase: The synergic mechanism for successful colonization and disease development. Toxins (Basel) 13, 485. https://doi.org/10.3390/toxins13070485 (2021).
Monteiro, M. A. et al. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J. Biol. Chem. 273, 11533–11543. https://doi.org/10.1074/jbc.273.19.11533 (1998).
Xu, N., Wang, W., Chen, F., Li, W. & Wang, G. ELISA is superior to bacterial culture and agglutination test in the diagnosis of brucellosis in an endemic area in China. BMC Infect. Dis. 20, 11. https://doi.org/10.1186/s12879-019-4729-1 (2020).
El-Kirat-Chatel, S., Boyd, C. D., O’Toole, G. A. & Dufrêne, Y. F. Single-molecule analysis of Pseudomonas fluorescens footprints. ACS Nano 8, 1690–1698. https://doi.org/10.1021/nn4060489 (2014).
Herman-Bausier, P. et al. Mechanical strength and inhibition of the Staphylococcus aureus collagen-binding protein CNA. mBio https://doi.org/10.1128/mBio.01529-16 (2016).
Gunning, A. P. et al. Use of atomic force microscopy to study the multi-modular interaction of bacterial adhesins to mucins. Int. J. Mol. Sci. 17, 1854. https://doi.org/10.3390/ijms17111854 (2016).
Sulchek, T. A. et al. Dynamic force spectroscopy of parallel individual Mucin1-antibody bonds. Proc. Natl. Acad. Sci. U.S.A. 102, 16638–16643. https://doi.org/10.1073/pnas.0505208102 (2005).
Dunker, K. et al. Elucidating bacterial adhesion to mucosal surface by an original AFM approach. BMC Microbiol. 21, 244. https://doi.org/10.1186/s12866-021-02303-1 (2021).
Mereiter, S., Balmaña, M., Campos, D., Gomes, J. & Reis, C. A. Glycosylation in the era of cancer-targeted therapy: Where are we heading?. Cancer Cell 36, 6–16. https://doi.org/10.1016/j.ccell.2019.06.006 (2019).
Pinho, S. S. & Reis, C. A. Glycosylation in cancer: Mechanisms and clinical implications. Nat. Rev. Cancer 15, 540–555. https://doi.org/10.1038/nrc3982 (2015).
Milland, J. et al. Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies. Immunol. Cell Biol. 85, 623–632. https://doi.org/10.1038/sj.icb.7100111 (2007).
Rondeel, J. M. M. Immunofluorescence versus ELISA for the detection of antinuclear antigens. Expert Rev. Mol. Diagn. 2, 226–232. https://doi.org/10.1586/14737159.2.3.226 (2002).
Ferreira, B., Marcos, N. T., David, L., Nakayama, J. & Reis, C. A. Terminal α1,4-linked N-acetylglucosamine in Helicobacter pylori-associated intestinal metaplasia of the human stomach and gastric carcinoma cell lines. J. Histochem. Cytochem. 54, 585–591. https://doi.org/10.1369/jhc.5A6836.2006 (2006).
Peng, W. et al. Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans. Glycobiology 22, 1453–1464. https://doi.org/10.1093/glycob/cws101 (2012).
Logan, S. M. et al. Novel biosynthetic functions of lipopolysaccharide rfaJ homologs from Helicobacter pylori. Glycobiology 15, 721–733. https://doi.org/10.1093/glycob/cwi057 (2005).
Veling, J., van Zijderveld, F. G., van Zijderveld-van Bemmel, A. M., Barkema, H. W. & Schukken, Y. H. Evaluation of three newly developed enzyme-linked immunosorbent assays and two agglutination tests for detecting Salmonella enterica subsp. enterica serovar Dublin infections in dairy cattle. J. Clin. Microbiol. 38, 4402–4407. https://doi.org/10.1128/JCM.38.12.4402-4407.2000 (2000).
Carlsson, H. E., Lindberg, A. A. & Hammarström, S. Titration of antibodies to salmonella O antigens by enzyme-linked immunosorbent assay. Infect. Immun. 6, 703–708. https://doi.org/10.1128/iai.6.5.703-708.1972 (1972).
Suzuki, T. et al. Mannose-specific lectin from the mushroom Hygrophorus russula. Glycobiology 22, 616–629. https://doi.org/10.1093/glycob/cwr187 (2011).
Nagae, M. et al. Phytohemagglutinin from Phaseolus vulgaris (PHA-E) displays a novel glycan recognition mode using a common legume lectin fold. Glycobiology 24, 368–378. https://doi.org/10.1093/glycob/cwu004 (2014).
Morello, E. et al. Evidence for the sialylation of PilA, the PI-2a pilus-associated adhesin of Streptococcus agalactiae strain NEM316. PLoS ONE 10, e0138103. https://doi.org/10.1371/journal.pone.0138103 (2015).
Campanero-Rhodes, M. A., Palma, A. S., Menéndez, M. & Solís, D. Microarray strategies for exploring bacterial surface glycans and their interactions with glycan-binding proteins. Front. Microbiol. 10, 2909. https://doi.org/10.3389/fmicb.2019.02909 (2019).
Tytgat, H. L. & Lebeer, S. The sweet tooth of bacteria: Common themes in bacterial glycoconjugates. Microbiol. Mol. Biol. Rev. 78, 372–417. https://doi.org/10.1128/mmbr.00007-14 (2014).
Champasa, K., Longwell, S. A., Eldridge, A. M., Stemmler, E. A. & Dube, D. H. Targeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp). Mol. Cell. Proteom. 12, 2568–2586. https://doi.org/10.1074/mcp.M113.029561 (2013).
Wadström, L. P. A. T. Helicobacter pylori: Physiology and Genetics Ch. 4 (ASM Press, 2001).
Lertsethtakarn, P., Ottemann, K. M. & Hendrixson, D. R. Motility and chemotaxis in campylobacter and helicobacter. Annu. Rev. Microbiol. 65, 389–410. https://doi.org/10.1146/annurev-micro-090110-102908 (2011).
Huang, Y., Wang, Q. L., Cheng, D. D., Xu, W. T. & Lu, N. H. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front. Cell Infect. Microbiol. 6, 159. https://doi.org/10.3389/fcimb.2016.00159 (2016).
Moonens, K. et al. Structural insights into polymorphic ABO glycan binding by Helicobacter pylori. Cell Host Microbe 19, 55–66. https://doi.org/10.1016/j.chom.2015.12.004 (2016).
Magalhães, A. et al. Muc5ac gastric mucin glycosylation is shaped by FUT2 activity and functionally impacts Helicobacter pylori binding. Sci. Rep. 6, 25575. https://doi.org/10.1038/srep25575 (2016).
Aspholm, M. et al. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2, e110. https://doi.org/10.1371/journal.ppat.0020110 (2006).
Ota, H. et al. Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch. 433, 419–426. https://doi.org/10.1007/s004280050269 (1998).
Javaheri, A. et al. Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. Nat. Microbiol. 2, 16189. https://doi.org/10.1038/nmicrobiol.2016.189 (2016).
Nguyen, Q. A., Schmitt, L., Mejías-Luque, R. & Gerhard, M. Effects of Helicobacter pylori adhesin HopQ binding to CEACAM receptors in the human stomach. Front. Immunol. 14, 1113478. https://doi.org/10.3389/fimmu.2023.1113478 (2023).
Paraskevopoulou, V. et al. Structural and binding characterization of the LacdiNAc-specific adhesin (LabA; HopD) exodomain from Helicobacter pylori. Curr. Res. Struct. Biol. 3, 19–29. https://doi.org/10.1016/j.crstbi.2020.12.004 (2021).
Senkovich, O. A. et al. Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils. Infect. Immun. 79, 3106–3116. https://doi.org/10.1128/iai.01275-10 (2011).
Teng, K. W. et al. Helicobacter pylori employs a general protein glycosylation system for the modification of outer membrane adhesins. Gut Microb. 14, 2130650. https://doi.org/10.1080/19490976.2022.2130650 (2022).
Acknowledgements
This research was partially performed at the RMIT Micro Nano Research Facility (MNRF), and the authors acknowledge the facilities and the scientific and technical expertise of the RMIT RNMF and the RMIT School of Science.
Funding
D.S. is supported by a Research Training Program Stipend Scholarship from the Australian Government, Department of Education and Training.
Author information
Authors and Affiliations
Contributions
D.S., A.E., A.K.W. and P.A.R. designed this study and wrote the manuscript. D.S., S.C. and A.E. performed the experiments. C.S., A.J.G., L.G.D. and A.M.S provided materials and intellectual guidance. All authors read and provided input on the manuscript and approved the final version.
Corresponding authors
Ethics declarations
Competing interests
A.J.G. is an employee of a company ZiP Diagnostics. L.G.D. is an employee, director, shareholder and cited on patents for Scancell. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sijmons, D., Collett, S., Soliman, C. et al. Probing the expression and adhesion of glycans involved in Helicobacter pylori infection. Sci Rep 14, 8587 (2024). https://doi.org/10.1038/s41598-024-59234-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-59234-w
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.